ES421767A2 - A PROCEDURE FOR THE PREPARATION OF 5-SULFAMYL-BENZOIC ACIDS REPLACED IN POSITION 2. - Google Patents
A PROCEDURE FOR THE PREPARATION OF 5-SULFAMYL-BENZOIC ACIDS REPLACED IN POSITION 2.Info
- Publication number
- ES421767A2 ES421767A2 ES421767A ES421767A ES421767A2 ES 421767 A2 ES421767 A2 ES 421767A2 ES 421767 A ES421767 A ES 421767A ES 421767 A ES421767 A ES 421767A ES 421767 A2 ES421767 A2 ES 421767A2
- Authority
- ES
- Spain
- Prior art keywords
- formula
- hydrogen
- bromine
- chlorine
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Improvements introduced in the object of the main patent No. 394,830 applied for on September 6, 1971 by: "A process for the preparation of 5-sulfamyl benzoic acids substituted in position 2" according to which when said acids are of the general formula: **(See formula)** and its amides, lower alkyl esters, and salts with pharmacologically acceptable bases; in the formula: Q is hydrogen, chlorine, fluorine, bromine, methoxy, methyl, dialkylamino lower, piperidino or hexamethyleneimino; T is chlorine, fluorine, bromine, methyl, methoxy, or trifluoromethyl; R16 is hydrogen or lower alkyl; R17 is lower alkyl or phenylalkylene of the formula: **(See formula)** in which: n has a value from 0 to 3 and each of the symbols R10 and R11 is hydrogen, methyl, chlorine, bromine or phenyl; and R16 and R17, when considered together with the nitrogen to which they are attached, form a heterocyclic ring selected from morpholino, piperidino, mono- and dimethylpiperidino or hexamethyleneimino; These improvements are characterized by: the reaction of an amine of the formula: **(See formula)** in which: R16 and R17 represent what is indicated above, with a compound of the formula: **(See formula)** in which: Hal is halogen and Q and T represent what is indicated above; and, if deemed convenient, then convert a compound of formula I, in which R16 is hydrogen, to N-alkyl by N-alkylization. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00318213A US3843662A (en) | 1971-12-09 | 1972-12-26 | 2-halo-5-(substituted piperidino sulfonyl)benzoic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES421767A2 true ES421767A2 (en) | 1977-07-01 |
Family
ID=23237158
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES421767A Expired ES421767A2 (en) | 1972-12-26 | 1973-12-24 | A PROCEDURE FOR THE PREPARATION OF 5-SULFAMYL-BENZOIC ACIDS REPLACED IN POSITION 2. |
| ES74425208A Expired ES425208A1 (en) | 1972-12-26 | 1974-04-10 | PROCEDURE FOR THE PREPARATION OF 5-SULFAMILBENZOIC ACIDS SUBSTITUTED IN POSITION 2. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES74425208A Expired ES425208A1 (en) | 1972-12-26 | 1974-04-10 | PROCEDURE FOR THE PREPARATION OF 5-SULFAMILBENZOIC ACIDS SUBSTITUTED IN POSITION 2. |
Country Status (11)
| Country | Link |
|---|---|
| JP (2) | JPS4986522A (en) |
| AR (1) | AR214849A1 (en) |
| AU (1) | AU6366973A (en) |
| BE (1) | BE808939R (en) |
| CA (1) | CA1012974A (en) |
| DE (1) | DE2363786A1 (en) |
| ES (2) | ES421767A2 (en) |
| FR (1) | FR2211261B2 (en) |
| GB (1) | GB1458029A (en) |
| NL (1) | NL7317455A (en) |
| ZA (1) | ZA739662B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1983000013A1 (en) * | 1980-11-10 | 1983-01-06 | Mochida Pharm Co Ltd | Medicinal composition having an antiviral effect |
| AU539797B2 (en) * | 1981-06-22 | 1984-10-18 | Hodogaya Chemical Co. Ltd. | Aminosulfonyl benzoic acid derivatives |
| SE8203878L (en) * | 1981-06-22 | 1982-12-23 | Mochida Pharm Co Ltd | VIRUS COMPOSITION |
| DE3732374A1 (en) * | 1987-09-25 | 1989-04-06 | Basf Lacke & Farben | ZINC, LEAD AND / OR CALCIUM SALTS OF CARBONIC ACIDS AND THE USE THEREOF AS A CORROSION PROTECT |
| DE19941540C2 (en) * | 1999-09-01 | 2002-08-29 | Aventis Pharma Gmbh | Sulfonylcarboxamides for the manufacture of medicaments for the prophylaxis or treatment of hyperlipidemia |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1122541B (en) * | 1959-12-28 | 1962-01-25 | Hoechst Ag | Process for the production of sulfamyl-anthranilic acids |
| FR1472906A (en) * | 1961-05-08 | 1967-03-17 | Parke Davis & Co | Esters of 4-halo-3-sulfamoylbenzoic acids and their production process |
| FR1450358A (en) * | 1960-09-03 | 1966-06-24 | Parke Davis & Co | Production of new 4-halogeno-3-sulfamylbenzamides |
| FR1311859A (en) * | 1961-09-18 | 1962-12-14 | Soc Ind Fab Antibiotiques Sifa | New sulfonamide derivatives, and method of preparation |
| US3565920A (en) * | 1966-12-29 | 1971-02-23 | Ciba Geigy Corp | 5-sulfamyl-anthranilic acids |
| US3567746A (en) * | 1968-07-10 | 1971-03-02 | Pennwalt Corp | N-aryl benzamides |
| US3700773A (en) * | 1969-06-25 | 1972-10-24 | Merck & Co Inc | Substituted phenylsulfamyl salicyclic acids and derivatives thereof in the treatment of inflammation |
-
1973
- 1973-12-10 GB GB5720773A patent/GB1458029A/en not_active Expired
- 1973-12-14 AU AU63669/73A patent/AU6366973A/en not_active Expired
- 1973-12-17 CA CA188,289A patent/CA1012974A/en not_active Expired
- 1973-12-20 NL NL7317455A patent/NL7317455A/xx not_active Application Discontinuation
- 1973-12-21 ZA ZA00739662A patent/ZA739662B/en unknown
- 1973-12-21 DE DE2363786A patent/DE2363786A1/en active Pending
- 1973-12-21 BE BE1005596A patent/BE808939R/en active
- 1973-12-24 ES ES421767A patent/ES421767A2/en not_active Expired
- 1973-12-26 FR FR7346294A patent/FR2211261B2/fr not_active Expired
- 1973-12-26 AR AR251706A patent/AR214849A1/en active
- 1973-12-26 JP JP48144187A patent/JPS4986522A/ja active Pending
-
1974
- 1974-04-10 ES ES74425208A patent/ES425208A1/en not_active Expired
-
1981
- 1981-12-01 JP JP56193584A patent/JPS5924975B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ZA739662B (en) | 1975-01-29 |
| FR2211261A2 (en) | 1974-07-19 |
| CA1012974A (en) | 1977-06-28 |
| AR214849A1 (en) | 1979-08-15 |
| GB1458029A (en) | 1976-12-08 |
| NL7317455A (en) | 1974-06-28 |
| FR2211261B2 (en) | 1977-04-15 |
| JPS5924975B2 (en) | 1984-06-13 |
| JPS58170756A (en) | 1983-10-07 |
| JPS4986522A (en) | 1974-08-19 |
| AU6366973A (en) | 1975-06-19 |
| DE2363786A1 (en) | 1974-07-11 |
| BE808939R (en) | 1974-06-21 |
| ES425208A1 (en) | 1976-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0040639A4 (en) | ISOXAZOL DERIVATIVES. | |
| ES410732A1 (en) | Olefinic 4-substituted piperidino derivatives | |
| ATE103592T1 (en) | CARBAMOYLPYRROLIDONE DERIVATIVES, THEIR USE AND MANUFACTURE. | |
| FR2398718A1 (en) | NEW PRIMARY AMINES USEFUL FOR THE PREPARATION OF AMINOALKYL BENZENE DERIVATIVES | |
| ES8503346A1 (en) | Alkanoylanilides. | |
| DK351788A (en) | TETRAHYDROISOQUINOLIN-2-YLD DERIVATIVES OF CARBOXYLIC ACIDS AS THROMBOXAN-A2 ANTAGONISTS | |
| SE7501365L (en) | ||
| FI852130A0 (en) | NYA SUBSTITUERADE PYRROLIDINONER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH CEEKEMEDEL. | |
| ES414159A1 (en) | 2-(Phenyl-amino-2-imidazolines and salts thereof | |
| ES411341A1 (en) | Hererocyclic derivatives of a guanidine | |
| KR850005433A (en) | Method for preparing naphthyridine and pyridopyrimidine compounds | |
| ES425208A1 (en) | PROCEDURE FOR THE PREPARATION OF 5-SULFAMILBENZOIC ACIDS SUBSTITUTED IN POSITION 2. | |
| ES479832A1 (en) | A PROCEDURE FOR PREPARING MERCAPTOACILAMINO ACIDS SUBSTITUTED WITH HALAGEN. | |
| ES394830A1 (en) | A PROCEDURE FOR THE PREPARATION OF 5-SULFAMYL-BENZOIC ACIDS REPLACED IN POSITION 2. | |
| ATE614T1 (en) | SUBSTITUTED 2-(BENZOYL)-GLYCINANILIDE DERIVATIVES, THEIR PREPARATION AND USE IN ANXIOLYTIC MEDICINES. | |
| ES435406A2 (en) | Pyrimidin-6-yl acethydroxamic acids, their therapeutic application and their process of preparation | |
| ES425216A1 (en) | Substituted triazolo-1,5-benzodiazepines | |
| SE8303131D0 (en) | ISOQUINOLINE DERIVATIVES | |
| ES468586A1 (en) | PROCEDURE FOR THE PREPARATION OF NEW PIRIDOBENZODIA- ZEPINONAS. | |
| ES448594A1 (en) | Diarylbutanolamines | |
| ES8502442A1 (en) | PROCEDURE FOR PREPARING NEW HETERO-CYCLE COMPOUNDS | |
| ES417269A1 (en) | PROCEDURE TO PREPARE IMIDAZOLIDINONE DERIVATIVES. | |
| SE8107680L (en) | PIPERAZINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF | |
| ES8501393A1 (en) | PROCEDURE FOR PREPARING NEW 4-HYDROXY-2H-1,2-BENZOTIAZIN-3-CARBOXAMIDE-1,1-DIOXIDES | |
| ES445339A1 (en) | A PROCEDURE FOR THE PREPARATION OF PYRROLIDI-NICOS DERIVATIVES. |